Roche Upbeat On Ocrevus Despite Consensus Miss

COVID-19 And Competition Slows Growth

 
• By Kevin Grogan
  
Pathway
Patients unwilling to change treatment pathways in the pandemic • Source: Shutterstock

More from Neurological

More from Therapy Areas